Pharma Talks

エピソード

• Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Michael Kurr 17.06.2026 14分

  In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Michael Kurr, a global transformation leader with 15+ years building large-scale commercial and medical affairs operations at Novartis and Boehringer Ingelheim, on what delivery at scale actually looks like in the AI era.Michael built content and delivery organizations of over 1,000 people — and he has some of the most direct takes on where pharma transformation is stalling.Key takeaways:Modular content served its purpose as a scalability crutch — but well-trained AI models will eventually make it obsoleteMLR is a bottleneck not just because of technology, but because of trust — local approvers carry legal liability and need confidence in what they sign offAI systems must become more explainable and deterministic before pharma can rely on AI-generated and AI-approved contentThe King Kong principle: having content is the easier part — getting the right content to the right customer at the right time, at scale, is the real challengeStaying relevant and staying current is the only viable strategy for individuals navigating AI-driven transformation📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Michael Kurr → https://www.linkedin.com/in/michaelkurr/
• Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Lauren Leahy 05.06.2026 3分

  In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Lauren Leahy, who leads global and international medical capabilities operations, on what AI really means for the people working inside pharma today.Lauren brings a medical affairs perspective to a conversation that's usually dominated by commercial voices.Key takeaways:AI isn't eliminating jobs — but it is fundamentally changing how they're structured and what skills they demandIn omnichannel, AI is actually increasing workload in the short term as teams redesign processes and upskillThe real opportunity isn't just productivity gains — it's system-level change and improved output qualityMedical and commercial functions need to work closer together around a single customer experienceStaying curious and adaptable — at both individual and company level — is the core competency for navigating what's ahead📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
• Pharma Talks with Nataliya Andreychuk | Live from NEXT Dubrovnik | Laetitia Huret 04.06.2026 5分

  In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk sits down with Laetitia Huret, Lead of Transformation at Servier, to explore what AI-driven commercial excellence actually looks like on the ground.Laetitia Huret works across global-to-local transformation, helping teams navigate digital, data, and AI change in the sales and commercial space.Key takeaways:The real question isn't whether AI will replace jobs — it's whether we're willing to keep ways of working that can be replacedAI's value in pharma lies in augmenting HCP engagement, not just accelerating content volumeHuman experience and accumulated knowledge remain the irreplaceable edge in an AI-assisted environmentEmbracing agentic and generative AI tools requires genuine investment in understanding them — not expecting magicThose not actively adopting AI risk falling behind in an industry-wide shift already underway📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk 🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
• Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 2 03.06.2026 19分

  Watch the first part of the conversation: https://youtu.be/PtR62juQ4FYThis episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.👥 Guests in this episode:Bruno Senouci - co-CEO at DRCOMGwenael Meneux - co-CEO at DRCOMKey Topics:AI impact on pharma communicationRegional differences in Asia healthcare marketsGlobal to local content adaptation strategiesContact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Follow Viseven and Nataliya, Bruno and Gwenael in social media: https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/bsenouci/https://www.linkedin.com/in/gwenael-meneux/?locale=fr
• Pharma Talks: AI in Pharma Communication – Breaking the Myths, Navigating Asia l Part 1 26.05.2026 19分

  Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQThis episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.👥 Guests in this episode:Bruno Senouci - co-CEO at DRCOMGwenael Meneux - co-CEO at DRCOMKey Topics:AI impact on pharma communicationRegional differences in Asia healthcare marketsGlobal to local content adaptation strategiesFollow Viseven and Nataliya, Bruno and Gwenael in social media: https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/bsenouci/https://www.linkedin.com/in/gwenael-meneux/?locale=fr
• Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Vanitha Venkatasubramaniam 11.05.2026 3分

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Vanitha Venkatasubramaniam, Associate Director at Novo Nordisk, for an honest conversation about where pharma stands today with AI — and where the real opportunity lies ahead.Vanitha brings a refreshingly balanced view: the skills aren't fully there yet, but the intention from leadership is. And the most exciting work? Using AI to genuinely improve the experience for HCPs and patients.Key takeaways:AI adoption in pharma is accelerating faster than most teams are ready forLeadership intent is strong — but building the right skills across teams remains the gapGenerative AI is already embedded in day-to-day workflows — Copilot, emails, meetingsThe biggest opportunity is using AI to enhance experiences for HCPs and patients, not just internal efficiencyThink beyond existing marketing models — combine them with technology to create innovative go-to-market approaches📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
• Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Maryna Alexeychuk 05.05.2026 4分

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice.Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day.Key takeaways:AI should be embedded where marketers already work — content, campaigns, reportingContextual, always-on AI beats standalone tools nobody opens twiceAI won't replace pharma marketers — human context in engagement is irreplaceableBefore choosing a technology, map your end-to-end processes and define your goal first📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
• Pharma Talks Live from Reuters Pharma Barcelona with Marc Koolen 04.05.2026 4分

  In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/marc-koolen/
• Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Haider Alleg 02.05.2026 6分

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that.With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and makes a bold claim: this isn't a technology shift. It's a culture shift.Key takeaways:AI in R&D and manufacturing is already mature — commercial operations are just catching upDark factories and agentic systems show what full automation can look likeThe biggest opportunity isn't automating tasks — it's re-internalizing operational work with AIMedical and scientific affairs are best positioned to lead the way right nowThe advice that matters most: get your hands dirty and stay curious📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect:🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙️ Haider Alleg → https://www.linkedin.com/in/haideralleg/
• Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Yacin Marzouki 30.04.2026 4分

  In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Yacin Marzouki, Founder and Leader of Beyond Health, to explore how AI is truly reshaping pharma marketing — and why the real transformation goes far deeper than individual pilots or content tools.Key takeaways:- AI in pharma marketing requires systemic thinking, not point solutions- Content without a delivery strategy is content that collects dust- Modular content isn't dead — it's just often implemented too early- Data hygiene and taxonomy are the boring work that makes everything else possible--📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)--🔗 Follow & Connect:🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙 Yacin Marzouki → https://www.linkedin.com/in/yacin-m-customerengagement/
• HCP Engagement in Pharma — Are We Actually Getting Better? l Pharma Talks with Nataliya Andreychuk 22.04.2026 32分

  Pharma has invested heavily in digital, CRM, and omnichannel — and yet the HCP engagement gap persists. In this episode, Nataliya Andreychuk talks with Mark Watson (Fractal Force) about why the problem is structural, not a failure of effort, and what it genuinely takes to close it: from fixing broken feedback loops to defining what "working" actually means at the behaviour level.Key Topics:The gap between digital investment and actual engagement resultsThe importance of foundational architecture in customer engagementThe role of feedback loops in improving HCP interactionsChallenges of content personalization and regulation in pharmaStrategic content design and journey logic in omnichannel marketingChapters00:00 Introduction to Customer Engagement Challenges02:22 Understanding the Gap in Pharma Engagement05:01 The Evolution of Customer Centricity07:56 Architecting Effective Engagement Strategies10:47 Content Creation and Regulatory Challenges13:45 Intelligent Content Design for Better Engagement16:25 Building a Feedback Loop for Success18:01 Making Engagement Real and Effective20:52 Practical Steps for Transformation23:33 Final Thoughts and RecommendationsFollow Nataliya Andreychuk and Mark in social media:https://www.linkedin.com/in/andreychuk/linkedin.com/in/markwatsonuk
• Pharma Talks Live from Philadelphia | AI, Omnichannel & Market Access Disruption 07.04.2026 29分

  In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond.👥 Guests in this episode:Rohit Khuttan — Practice Director, Everest GroupOn AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise mindset is the #1 thing that needs to change.Ruslan Horblyuk — Chief Strategy Officer, AESARAOn AI in market access, health technology assessments, trust in AI data, and whether human-in-the-loop will always be necessary.Nihar Patel — Business Development, Sun PharmaOn generative, predictive and communicative AI, breaking data silos, and the three pharma areas set for the biggest disruption.Key topics covered:Is Omnichannel really a content problem, not a channel problem?How AI is changing content production and the pharma supply chainCan we trust AI data in market access decisions?Will AI replace pharma professionals — or make them smarter?The three pharma disciplines AI will disrupt first📲 Enjoyed this episode?👉 Like, Subscribe & hit the to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at Reuters Pharma Barcelona
• Pharma Talks: Building Trust in Agentic AI in Pharma 27.03.2026 13分

  In this episode of Pharma Talks, Natalyia Andreychuk and Anna Shavurska explore trust in AI, especially agentic AI in pharma, the importance of women in tech, and how AI can be developed responsibly with a focus on safety, trust, and diversity.Takeaways:Trust in agentic AI and safety measures in pharmaThe importance of women in AI development and diversityTechnical approaches to secure and reliable AI, including knowledge bases and retrieval-augmented generationChapters00:00 Introduction to AI Trust and Women in Tech02:00 Understanding Agentic AI and Knowledge Base Security03:45 Ensuring Data Privacy and Trust in Pharma AI05:39 Technical Challenges in Visual and Text Generation07:35 Prompt Engineering and AI Output Precision09:50 The Importance of Women in AI Development11:38 Historical Bias and the Need for Diversity in AI12:39 Inspiration and Career Path in AI13:30 Closing Remarks and Future of Women in AI
• Content Supply Chain in Pharma | Pharma Talks 21.02.2026 24分

  Content Supply Chain in Pharma | Pharma TalksIn this conversation, Nataliya Andreychuk and Prasant Vijayakumar discuss the importance of the content supply chain in the pharmaceutical industry, exploring how AI is transforming content development, the relevance of modular content, and the challenges faced in ensuring effective engagement.TakeawaysContent supply chain is crucial for effective communication in pharma. AI is changing the landscape of content development. MLR processes can be streamlined to enhance efficiency. Modular content remains relevant in today's digital age. Structured data is essential for effective content management. Content velocity affects how quickly updates can be communicated. Localization is key to successful content adoption. Integration of various content formats is necessary for engagement. The future of content creation will involve more video formats. Challenging the status quo of MLR can lead to significant improvements.Chapters00:00 Introduction to Content Supply Chain in Pharma 02:18 The Role of AI in Content Development 05:11 Modular Content: Relevance and Education 07:50 Challenges in Content Structure and Data 10:26 Content Velocity and Engagement 13:03 The Future of Content Supply Chain 15:58 Localization and Infrastructure in Content Delivery 18:50 Conclusion and Future Outlook Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
• Rise of Digital Opinion Leaders in Pharma | Pharma Talks 11.02.2026 23分

  In this episode of PharmaTalks, Nataliya Andreychuk explores the rise of digital opinion leaders with pharma omnichannel and digital engagement expert Pavlo Klymenko. The conversation goes beyond influencers and traditional key opinion leaders, focusing on a new type of voice emerging naturally in open and social media. Clinicians who build trust, share practical experience, and engage peers and patients in a more open, continuous way.Takeaways Digital opinion leaders are more than just influencers; they provide credible medical information.There is a significant gap between guidelines and real-world practices in healthcare.Patients increasingly seek information from social media rather than healthcare professionals.Effective communication requires constant dialogue with clinicians.Digital opinion leaders can help fill the gap left by misinformation online.Pharma must adapt to the fast-paced changes in healthcare communication.Engagement with digital opinion leaders should be honest and transparent.The role of digital opinion leaders is essential for product launch readiness.Pharma companies need to invest time and resources in building relationships with digital opinion leaders.Creating reusable content for digital opinion leaders can enhance communication efficiency. ****Chapters 00:00 Introduction to Digital Opinion Leaders01:55 The Shift from KOLs to DOLs03:33 Understanding Pharma's Engagement with DOLs07:18 Challenges and Opportunities in Digital Engagement11:09 The Role of Medical Governance in DOL Engagement15:24 Building Effective Relationships with DOLs17:28 Practical Steps for Pharma Companies20:20 Hot or Not: Challenging the Status Quo***🔗 Links for more insights:https://viseven.com/key-opinion-leaders-in-pharma/https://viseven.com/healthcare-marketing-plan-guide/https://viseven.com/patient-engagement-in-pharma/https://viseven.com/pharma-crm/https://viseven.com/mlr-review-process-in-pharma-challenges-and-solutions/https://viseven.com/digital-transformation-in-pharma/https://viseven.com/life-sciences-industry-trends-2026/Follow Viseven, Nataliya, and Pavlo in social media: https://www.linkedin.com/company/2907491https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/pavel-klymenko-2956395/
• Rethinking Omnichannel Marketing in Pharma | Pharma Talks 03.02.2026 26分

  In this episode of PharmaTalks, Nataliya Andreychuk and Nico Renner discuss the evolving landscape of pharma marketing, particularly focusing on the concept of omnichannel marketing. They explore the challenges and misconceptions surrounding omnichannel strategies, the importance of personalization versus segmentation, and the role of AI in enhancing marketing efforts. The conversation emphasizes the need for a more human touch in marketing and practical steps that pharma teams can take to improve their strategies.Nico Renner is strictly sharing is personal views and opinion as an individual, not his current employer’s position on the discussed topics.TakeawaysOmnichannel marketing is often misunderstood and overhyped.Personalization should be distinct from segmentation in marketing.The human element in marketing is crucial for effective engagement.AI can help streamline marketing processes but should focus on relevance.Pharma marketers face increasing pressure to be multifaceted experts.Segmentation can be more effective than personalization at scale.The industry needs to recalibrate its expectations from omnichannel strategies.Marketers should prioritize creating relevant content over sheer volume.The future of pharma marketing lies in understanding patient needs better.A more human touch in marketing will be increasingly valued.Chapters00:00 Introduction to Omnichannel Marketing in Pharma02:08 The Evolution of Pharma Marketing04:46 Rethinking Omnichannel: Overrated or Misunderstood?08:18 Personalization vs. Segmentation: A Misalignment?19:22 Practical Steps for Pharma's Future24:33 Hot or Not: Myths in Pharma Marketing🔗 Links for more insights:https://viseven.com/omnichannel/https://viseven.com/content-development/https://viseven.com/difference-multichannel-omnichannel-pharma-communication-many-overlooked/https://viseven.com/using-omnichannel-approach-to-achieve-better-hcp-engagement-how-does-it-work/Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Follow Viseven, Nataliya, and Paul in social media:https://www.linkedin.com/company/2907491/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/nicorenner
• Human Element in Digital Transformation | Pharma Talks 26.01.2026 28分

  In this engaging conversation, Nataliya Andreychuk and Paul Tunnah discuss the evolving landscape of the pharmaceutical industry as they approach 2026. They explore the importance of digital transformation, emphasizing the need for a human-centric approach rather than a technology-first mindset. The discussion delves into the risks and rewards associated with AI in pharma, the significance of customer engagement, and the challenges of hyper-personalization versus effective segmentation. TakeawaysDigital transformation must prioritize human change over technology.AI presents both risks and rewards that need careful consideration.Customer engagement strategies should focus on building trust and connection.Segmentation is crucial for effective communication in pharma.Hyper-personalization may not be the best approach for all situations.Content quality is essential to cut through the noise in marketing.Companies should embrace a mindset of continuous evolution and adaptation.Collaboration between IT and business leaders is vital for success.The future of pharma will require a balance between technology and human insight.2026 will be a pivotal year for the pharmaceutical industry. Chapters00:00 Introduction and Year-End Reflections03:05 Digital Transformation and the Human Element05:48 AI, Risk, and Reward in Pharma08:35 Customer Engagement and the Future11:28 Navigating AI and Content Creation14:22 Hyper-Personalization vs. Segmentation17:04 Hot or Not: Industry Predictions25:52 Conclusion and Looking Ahead to 2026Watch, listen, and reflect before you plan your 2026 strategy
• AI and Marketing: The Smart Shift in Pharma | Pharma Talks 16.01.2026 29分

  Discover how AI is reshaping pharma – from marketing automation to intelligent sales strategies – with our guest Fredrik Holmboe. Listen to the new Pharma Talks episode with Nataliya Andreychuk! Together, they explore how the role of the modern marketeer is evolving – from content creators to AI-driven orchestrators of omnichannel engagement. The conversation uncovers how AI in sales and marketing is reshaping daily operations, driving smarter decisions, and creating a seamless bridge between sales, marketing, and medical teams. Key topics explored in this episode: The shift from traditional marketing to AI and digital marketing approaches.How AI for sales and marketing empowers teams with predictive insights and real-time personalization.Practical examples of AI-driven sales enablement and content intelligence tools improving HCP engagement.Bridging organizational silos through data intelligence, automation, and AI for customer experience.Fredrik's ABC+ Content Excellence Framework – helping life science companies enhance digital engagement in pharma and ensure unified messaging across all channels.What the future holds for AI adoption in life science, pharma business transformation, and human-AI co-creation. Tune in to discover where creativity meets intelligence, and technology becomes the enabler of more meaningful healthcare communication! Find out more about ABC+ Content Excellence Framework: https://www.dualia.se/Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert SupportDiscover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ ***0:00 Intro03:14 The evolving role of marketers in Pharma06:09 Real-world applications of AI in marketing17:17 Bridging gaps: sales, marketing, and medical collaboration22:59 The future of marketing: orchestrating AI tools ***Follow Viseven, Nataliya, and Fredrik in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/https://www.linkedin.com/in/fredrikholmboe/ ***🔗 Links for more insights:https://viseven.com/ai-data/https://viseven.com/healthcare-data-analytics/https://viseven.com/ai-medical-affairs/https://viseven.com/list-of-ai-mistakes-pharma-companies-make/
• Pharma 2026: Connecting AI, People, and Processes | Pharma Talks with the Viseven Team 30.12.2025 31分

  In this episode, Viseven leaders reflect on the trends shaping the pharmaceutical industry today. The discussion focuses on how digital transformation is evolving from isolated initiatives into connected systems that support real business execution. Automation and AI are no longer optional, but their value depends on how well they are integrated into existing workflows and operating models.This episode looks ahead to what’s next for pharma and life sciences, and what it takes to operationalize AI in a way that strengthens teams rather than replaces them.Key topics explored in this episode:The pharmaceutical industry is increasingly focusing on digital transformation and automation.Companies are rationalizing their systems to integrate AI more effectively.AI should be part of the core processes, not a separate entity.People and processes are crucial for successful tech integration.2026 will see a shift from AI pilots to operationalized solutions.AI will be integrated into teams to enhance productivity.The role of professionals will evolve to be more technology-savvy and cross-functional.There are challenges in balancing AI capabilities with human creativity.The industry must adapt quickly to the changing landscape of AI.Strategic thinking in the AI era requires a new approach to roles and responsibilities.***Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert SupportDiscover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ ***00:00 Introduction to Pharma Talks and Team Insights 00:56 Trends in Pharma: Digital Transformation and Automation 03:04 The Role of People and Processes in Tech Integration 05:08 Forecasting 2026: Operationalizing AI in Pharma 08:27 Challenges and Opportunities in the AI Era ***Follow Viseven, Nataliya in social media:https://www.linkedin.com/company/viseven/https://www.linkedin.com/in/andreychuk/
• Pharma Talks: Human Leadership + AI Adoption: Clear Strategy 2026 18.12.2025 39分

  The discussion between Nataliya and Paul serves as a reminder that the pharmaceutical industry stands at a crossroads where embracing change can lead to unprecedented opportunities. By trusting their creativity, shifting their mindsets, and focusing on quality over quantity, professionals can navigate the evolving landscape and make a lasting impact in healthcare. Key topics explored in this episode: Technological change should be embraced, not feared. Understanding customer needs is crucial for innovation. Pharma must trust its own capabilities and creativity. Predictions for the future should be bold and visionary. Quality of content is more important than quantity. Compliance should be integrated into marketing strategies. Agility in launch strategies is essential for success. A human-centric approach is vital in the age of AI. Patient-centricity must be balanced with scientific integrity. Proactive engagement with technology will shape the future of pharma. Chapters 00:00 Introduction and Overview of Pharma's Future 02:31 Embracing Change in Pharma 05:16 The Role of Customer Insights 08:00 Trusting Ourselves in Pharma Marketing 10:50 Predictions for 2026: A Visionary Outlook 13:42 Content Production and Its Evolution 16:24 The Future of Compliance in Pharma 19:12 Rethinking Launch Strategies 23:13 Embracing Agility and Evolution in Marketing 25:00 The Human Element in AI Integration 27:40 Navigating the Future of Work and Technology 29:41 Rethinking Patient-Centricity in Healthcare 33:44 Rapid Fire Insights on Industry Trends Listen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions. Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ *** Follow Viseven, Nataliya, and Paul in social media: https://www.linkedin.com/company/viseven/ https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/psimms/ ***